Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01533688 · ClinicalTrials.gov registry record · NA
Study of Efficacy and Tolerability of Various Bowel Preps in Diabetic Patients
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
NCT01533688: Completed NA study, sponsored by University of Oklahoma.
NCT01533688 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 212 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01533688, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
Study Summary
Poor bowel preparation and patient intolerance of the procedure are the most important factors contributing to the limitation of colonoscopy. Inadequate bowel cleansing results in incomplete testing, increased potential to miss lesions, increased cost, and decreased patient satisfaction. The investigators hope to gain better insight into which bowel preparation works best in diabetic patients and hence would increase patient satisfaction, tolerability of the bowel preparation and decrease overall costs. The investigators will investigate which bowel preparation for colonoscopy will work optimally in diabetic patients using three different regimens.
Primary Outcome
The investigators will measure the number/% of participants who will have good to excellent bowel preparations defined by the Boston Bowel Prep Scale(BBPS) with a score of 6 or more, rated by blinded colonoscopist.
Interventions
- DRUG Golytely (polyethylene glycol electrolyte lavage solution) and placebo
- DRUG split dose of Golytely (polyethylene glycol electrolyte lavage solution) + placebo
- DRUG split dose of Golytely (polyethylene glycol electrolyte lavage solution) and bisacodyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT01533688 record still lists
NCT01533688 is an interventional study that assigns participants to a tested intervention. The registered 212 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Golytely (polyethylene glycol electrolyte lavage solution) and placebo is the first listed.
NCT01533688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01533688 about?
NCT01533688 is a clinical study titled "Study of Efficacy and Tolerability of Various Bowel Preps in Diabetic Patients". Poor bowel preparation and patient intolerance of the procedure are the most important factors contributing to the limitation of colonoscopy. Inadequate bowel cleansing results in incomplete testing, increased potential to miss lesions, increased cost, and decreased patient satisfaction. The investi...
What is the current status of trial NCT01533688?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2011-10. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01533688?
The interventions under investigation include: Golytely (polyethylene glycol electrolyte lavage solution) and placebo (DRUG), split dose of Golytely (polyethylene glycol electrolyte lavage solution) + placebo (DRUG), split dose of Golytely (polyethylene glycol electrolyte lavage solution) and bisacodyl (DRUG).
Who is sponsoring clinical trial NCT01533688?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01533688's enrollment target sits among peer trials
212 489th of 2000 higher than 1,511 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
- NCT06456593 · 212 participants · Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia